Ratings by Roth/MKM (Scott Henry)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/15/2023 | RenovoRx Inc. | RNXT | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2023 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2023 | Reviva Pharmaceuticals | RVPH | New Coverage | Buy (N/A) |
5.40 (0.18) |
-96.67% | Details | |
| 8/21/2023 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/23/2023 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2023 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Prosomnus | OSA | New Coverage | Buy (N/A) |
5.17 (0.47) |
-90.91% | Details | |
| 4/12/2023 | Assure Holdings Corp. | IONM | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2022 | Assure Holdings Corp. | IONM | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Myomo Inc. | MYO | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2022 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2022 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2022 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2022 | Catalyst Pharmaceutical Partners | CPRX | Downgrade | Neutral (Buy) |
14.91 (24.24) |
62.58% | Details | |
| 8/10/2022 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Myomo Inc. | MYO | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Medexus Pharmaceuticals Inc. | MEDXF | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2022 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | Assure Holdings Corp. | IONM | New Coverage | Buy (N/A) |
2.05 (2.43) |
18.54% | Details | |
| 6/7/2022 | INVO Bioscience Inc. | INVO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/20/2022 | Vivos Therapeutics | VVOS | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | Inmed Pharmaceuticals | INM | Upgrade | Buy (Neutral) |
0.83 (0.92) |
10.84% | Details | |
| 5/13/2022 | Myomo Inc. | MYO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2022 | INVO Bioscience Inc. | invo | Downgrade | Neutral (Buy) |
2.07 (0.83) |
-59.9% | Details | |
| 3/10/2022 | Myomo Inc. | MYO | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Journey Medical Corp. | DERM | New Coverage | Buy (N/A) |
6.75 (5.14) |
-23.85% | Details | |
| 11/16/2021 | Vivos Therapeutics | VVOS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | RenovoRx Inc. | RNXT | New Coverage | Buy (N/A) |
5.18 (0.79) |
-84.75% | Details | |
| 5/14/2021 | Inmed Pharmaceuticals | INM | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | INVO Bioscience Inc. | INVO | New Coverage | Buy (N/A) |
3.07 (0.83) |
-72.96% | Details | |
| 12/4/2020 | Bionano Genomics | BNGO | Downgrade | Neutral (Buy) |
0.49 (1.12) |
128.57% | Details | |
| 11/11/2020 | Myomo Inc. | MYO | Upgrade | Buy (Neutral) |
4.74 (0.80) |
-83.12% | Details | |
| 8/4/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2020 | Champions Oncology | CSBR | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2020 | Delcath Systems | DCTH | New Coverage | Buy (N/A) |
7.78 (9.08) |
16.71% | Details | |
| 3/30/2020 | BioSig Technologies Inc. | BSGM | New Coverage | (N/A) |
6.13 (6.10) |
-0.49% | Details | |
| 3/27/2020 | Soliton | SOLY | New Coverage | Buy (N/A) |
8.80 (22.58) |
156.59% | Details | |
| 3/16/2020 | Myomo Inc. | MYO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2019 | Zynerba Pharmaceuticals | ZYNE | New Coverage | Buy (N/A) |
5.64 (1.30) |
-76.95% | Details | |
| 11/14/2019 | Myomo Inc. | MYO | Downgrade | Neutral (Buy) |
0.69 (0.80) |
15.94% | Details | |
| 10/11/2019 | Intec Pharma Ltd. | NTEC | Downgrade | Neutral (Buy) |
0.72 (9.63) |
1237.5% | Details | |
| 9/30/2019 | Daxor Corp. | DXR | New Coverage | Neutral (N/A) |
9.62 (11.38) |
18.3% | Details | |
| 9/25/2019 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2019 | Champions Oncology | CSBR | New Coverage | Buy (N/A) |
6.08 (5.87) |
-3.45% | Details | |
| 9/5/2019 | Kempharm | KMPH | Downgrade | Neutral (Buy) |
0.95 (5.81) |
511.58% | Details | |
| 5/9/2019 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2019 | Tonix Pharma | TNXP | Upgrade | Buy (Neutral) |
2.43 (13.45) |
453.5% | Details | |
| 4/3/2019 | BioPharmX Corp | BPMX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Recro Pharma | REPH | Downgrade | Neutral (Buy) |
9.72 (2.09) |
-78.5% | Details | |
| 3/18/2019 | Restoration Robotics | HAIR | Downgrade | Neutral (Buy) |
0.90 (0.38) |
-57.78% | Details | |
| 12/31/2018 | Dynatronics | DYNT | New Coverage | Buy (N/A) |
2.86 (0.24) |
-91.61% | Details | |
| 12/17/2018 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2018 | Q BioMed | QBIO | Downgrade | Neutral (Buy) |
1.90 (0.00) |
-100% | Details | |
| 11/7/2018 | Recro Pharma | REPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2018 | Ligand Pharma | LGND | Upgrade | Buy (Neutral) |
167.06 (201.90) |
20.85% | Details | |
| 10/5/2018 | Intec Pharma Ltd. | NTEC | New Coverage | Buy (N/A) |
5.20 (0.72) |
-86.15% | Details | |
| 9/4/2018 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2018 | Lannett Co | LCI | Downgrade | Neutral (Buy) |
13.50 (0.69) |
-94.89% | Details | |
| 8/16/2018 | Ritter Pharmaceuticals | RTTR | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2018 | Restoration Robotics | HAIR | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2018 | BioDelivery Sciences International | BDSI | Maintain | Buy (N/A) |
|
Details |
